← Back to Clinical Trials
Recruiting NCT05589155

NCT05589155 Efficacy of Using Mobile Health Applications for Health

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05589155
Status Recruiting
Phase
Sponsor San Diego State University
Condition Diabetes Mellitus, Type 2
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2022-10-01
Primary Completion 2028-07-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 64 Years
Study Type INTERVENTIONAL
Interventions
Mobile health application

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2022-10-01 with a primary completion date of 2028-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to determine the effectiveness of mobile health applications in improving health outcomes and type II diabetes outcomes in type 2 diabetics. This study will involve a 6-month long commitment where participants will be expected to weigh themselves every morning, at the same time, and check their blood glucose readings daily before and after meals for at least three meals in the day.

Eligibility Criteria

Inclusion Criteria: * Diagnosed with type II diabetes for at least 3 months * Between the age of 18-64 * BMI ≥ 25 * Monitors blood glucose regularly (at least once per day) * Owns or has access to a bathroom weight scale * Owns a smartphone and willing to download mobile app Exclusion Criteria: * Does not check blood glucose at least once per day * On medications that promote weight gain such as antipsychotic, antidepressant, and steroid hormone medications. Medications for diabetes such as insulin, thiazolidinediones or sulfonylureas are oka

Frequently Asked Questions

Who can join the NCT05589155 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 64 Years, studying Diabetes Mellitus, Type 2. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05589155 currently recruiting?

Yes, NCT05589155 is actively recruiting participants. Visit ClinicalTrials.gov or contact San Diego State University to inquire about joining.

Where is the NCT05589155 trial being conducted?

This trial is being conducted at San Diego, United States.

Who is sponsoring the NCT05589155 clinical trial?

NCT05589155 is sponsored by San Diego State University. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology